I would buy and hold Cochlear and these ASX healthcare shares

Cochlear Limited (ASX:COH) and these ASX healthcare shares could be great buy and hold options right now…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

According to research by the World Health Organization, between 2015 and 2050, the proportion of the world's population over 60 years will almost double from 12% to 22%.

This is expected to lead to increasing demand for healthcare services over the next three decades, which is why I think the healthcare sector is a great place to consider long term buy and hold investments.

Three healthcare shares that I would buy are listed below. Here's why I like them:

Cochlear Limited (ASX: COH)

As people age their hearing will invariably deteriorate and require some form of assistance. In light of this, I think Cochlear is well-positioned for long term growth due to being a leading manufacturer and distributor of cochlear implantable devices for the hearing impaired globally. Thanks to this and the industry's high barriers to entry, I remain confident that Cochlear can continue being a market beater over the next decade.

Nanosonics Ltd (ASX: NAN)

Another healthcare share which I think could be a great buy and hold option is Nanosonics. At present the infection control specialist is generating all its revenue from its industry-leading trophon EPR disinfection system for ultrasound probes. Whilst I believe this product and the consumables it requires will underpin solid earnings growth over the next decade, they will soon be joined by a range of new products which are under development and targeting unmet needs. If these are only half as successful as trophon EPR, it bodes well for Nanosonics' long term growth.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara Health Technologies is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Its software aims to help clinicians better understand their patients and administrators better understand their practices. And judging by its increasing popularity in North America, it is delivering on its promise. This year the company is on track to deliver annual recurring revenue (ARR) growth of 158% to NZ$17.1 million and a 27% footprint in the United States.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd., Nanosonics Limited, and VOLPARA FPO NZ. The Motley Fool Australia has recommended Cochlear Ltd., Nanosonics Limited, and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »